Drug Profile
Research programme: hypertension therapeutics - Bristol-Myers Squibb
Alternative Names: BMS-346567; BMS-465149; BMS-509701Latest Information Update: 04 Oct 2006
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Isoxazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Endothelin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension